|Articles|December 15, 2022
How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions
Author(s)PwC
In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. While these third-party relationships can be full of risk and regulatory challenges, the right tech can help you navigate the complexities of compliance.
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK
2
Replimune Shares Crash Following FDA Review of Melanoma Treatment
3
Addressing Launch Drift to Optimize Product Launches
4
When Foreign Investments in Pharma and Biotech Become a National Security Concern
5